🚨 Early bird registration for #KfG2025 closes 15 Feb 2025, 23:59 CEST! Join our top life sciences event to connect, learn, and discover the future of #biotech, #pharma, #medtech & #healthtech 🌱 💸 Don’t miss the best rate — register now 👉 #lifesciences

Researchers at @VIB_microbes and @CBD_VIB revealed the relationship between #ProteinAggregation and #BacterialDormancy, states during which bacteria are not susceptible to #antibiotics. 🧫

New research by the team of Prof. Charlotte Scott (@VIBLifeSciences) reveals that a specific activation state of one of the immune cell types in our livers is required for tissue repair following injury. 🔗

A strong #BiotechAct is a vital step towards unlocking the full potential of #biotechnology to support healthy citizens, robust economies, and a sustainable future. Read more about this visionary approach below ⬇

🚀 EuropaBio’s vision for the #EUBiotechAct marks a transformative step for the entire #biotech sector.

BioSPX announces a new #collaboration with Amphasys, specialized in Impedance Flow Cytometry technology for #SingleCellAnalysis. 🔗

💭 Intellectual property specialist @GEVERS_IP and IP law firm CAPE IP Law are joining forces to consolidate their expertise in #IntellectualProperty. 🔗

🤝 @ONTOFORCE and Rancho BioSciences have announced a joint #collaboration transforming data-driven research and drug development. 🔗

@KU_Leuven's lab and @SandboxAQ are teaming up to fast-track Parkinson's drug discovery using #AI to restore #ATP10B, a key protein for brain cell survival. 🧠

New research by @vib_ccb shows that #aspartate plays a key role in driving lung #metastasis in #cancer. The study, published in @Nature, reveals how aspartate activates a signaling pathway that boosts cancer cell aggression in the #lung. 🫁

Researchers of @CBD_VIB reveal differences in #braincells and their potential link to #autism and mental health disorders such as #schizophrenia. 🧠

@SequanaMed’s #alfapump significantly improves ascites control and quality of life for patients with #cirrhosis and refractory #ascites, as published in the American Journal of Gastroenterology. 🔗

@GalapagosGlobal will separate into two entities by mid-2025: 1️⃣ a new company focused on innovative medicines 2️⃣ Galapagos, which will continue to advance its global leadership in #celltherapy 📢

Game changer for #osteoarthritis: Allegro’s injectable microparticle gel, #hydrocelin, acts as tiny shock absorbers to relieve pain, protect cartilage, and restore mobility. Preclinical studies show promising safety results.

Exciting news! @Bennotx has won the award for “Most Innovative Animal Health Project” at the #BioFit conference for their groundbreaking treatment for bladder cancer in #animals.

Scientists at @VIBLifeSciences, @VUBrussel, @ugent & @eTheRNA_engine unveil a groundbreaking mRNA immunotherapy platform using lipid-based nanoparticles (LNPs). This innovation boosts the immune system to target cancer cells. 🧬

Promising news! @GalapagosGlobal’s Phase 1/2 ATALANTA-1 study of GLPG5101 shows encouraging efficacy & safety in patients with relapsed/refractory non-Hodgkin lymphoma. A big step forward in #cancer treatment! 💡

Exciting news in Alzheimer's research! @muna_tx partners with @GSK to uncover new drug targets for Alzheimer’s using Muna's innovative MiND-MAP platform.

@VUBrussel and @VIBLifeSciences @structbiolbxl have joined forces to launch the brand-new Bio Incubator Brussels (BIB) in Etterbeek. This hub brings together science, technology and entrepreneurship, to transform biotech breakthroughs into companies.